GlassScriptPhysician profile
Laurie Luna
NPI 1689023822
$1,929.83
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $623 · 2023: $899 · 2024: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $413.29 | 2022-2024 | Jynarque |
| Amgen INC. | $331.43 | 2022-2024 | Tavneos |
| Bayer Healthcare Pharmaceuticals INC. | $331.32 | 2022-2024 | |
| Abbott Laboratories | $126.94 | 2021 | |
| Calliditas Therapeutics US INC. | $108.52 | 2022-2023 | Tarpeyo |
| Daiichi Sankyo INC. | $103.27 | 2022-2023 | Injectafer |
| Travere Therapeutics, INC. | $100.87 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.64 | 2022-2023 | Gattex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.67 | 2021 | |
| Alexion Pharmaceuticals, INC. | $53.19 | 2022 | |
| Glaxosmithkline, LLC. | $52.78 | 2022 | |
| Ani Pharmaceuticals, INC. | $48.79 | 2023-2024 | Purified Cortrophin Gel |
| Alnylam Pharmaceuticals INC. | $27.21 | 2023 | Oxlumo |
| Fresenius USA Marketing, INC. | $23.26 | 2024 | |
| Novo Nordisk INC | $17.51 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.35 | 2021 | |
| Vifor Pharma, INC. | $16.12 | 2022 | |
| Aurinia Pharma U.S., INC. | $13.80 | 2023 | Lupkynis |
| Akebia Therapeutics INC | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Luna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.